Shares of Resverlogix Corp. (TSE:RVX – Get Free Report) passed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of C$0.06 and traded as low as C$0.06. Resverlogix shares last traded at C$0.06, with a volume of 1,000 shares changing hands.
Resverlogix Stock Down 9.1 %
The business has a fifty day simple moving average of C$0.06 and a two-hundred day simple moving average of C$0.06. The company has a market cap of C$13.85 million, a P/E ratio of -1.00 and a beta of 0.71.
About Resverlogix
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Read More
- Five stocks we like better than Resverlogix
- Overbought Stocks Explained: Should You Trade Them?
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- What Is WallStreetBets and What Stocks Are They Targeting?
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- Investing In Automotive Stocks
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
